Trade ideas in bold.
NVDQ +95% Up on acquisition by Stryker. Almost 100% premium.
CLVS +47% Up on its ph 3 trial reaching primary endpoint of PFS to treat advanced ovarian cancer. Is competing with TSRO, TSRO fell at the beginning of the day but recovered all its losses.
ZN +32% Up on a successful early milestone on its well drilling. Stock opened flat then shot up about 80% by 10am before sliding back down. Since it's only an early milestone, the stock will likely fade tomorrow.
NH +22% No news explaining why it's up so much. Is a very volatile stock with a character for a CEO, Chinese billionaire Soon-Shiong. Expect a fade tomorrow.
CAI +15% Up on debt offering and expansion of credit facility. Is a transportation finance and logistics company. Stocks rarely hold gains after issuing debt. Expect a fade tomorrow.
NTLA +14% A CRISPR biotech. Up on patent announcement. Stocks up on patent news usually fade, being a $500M market cap stock, it's weak rally likely isn't sustainable for more than a day, expect a fade tomorrow.
FCSC +14% A microcap biotech. No news explaining why it's up.
BLCM +14% No news explaining why it's up. Is a CART biotech.
MRTX +13% Microcap biotech with a history of failures, no news explaining why its up.
RMP -27% Down from RICE acquisition. Because RMP it may no longer be a public MLP.
CLSN -14% An expected fade after it soared friday just because it withdrew a share offering - not solid fundamental news. The company will have to still raise money.
OMNT -15% A fade after a recent dead cat bounce in the stock.
KURA -9% Smallcap bio, no news explaining its rise.
EQT -9% Down on news of its acquisition. Strange, most acquisitions cause the acquiring company to go up.
AMID -9% Retraced back down after rallying on Friday.
SXE -8% Continues downtrend, no news explaining why.
VBIV -8% Says its phase III discussions with the FDA were "positive", investors disagree.
RVLT -7% No news explaining why it's down.
AKTS -7% No news explaining why its down, other than air coming out of this pump and dump.